ÂÜÀòÂÒÂ×

Mark Adler is responsible for product development activities.

Mark has 25+ years of medical device development and operations experience launching novel technologies in cardiovascular, neurovascular, pulmonology and diabetes continuous glucose monitoring. He most recently was Senior Director R&D and Vice President of Global Operations at JenaValve Technologies where he managed the Next Generation Aortic Valve Delivery System and Heart Valve development addressing Aortic Regurgitation and Aortic Stenosis to move project at accelerated pace for clinical introduction and design validation. Prior to that, he has held positions as Director and Vice President in Development and Operations in multiple start up organizations supporting product performance assessment, product optimization, product analysis and commercial validation readiness. Organization support activities bounded all activities in product process development, supply chain management in all modalities of supply chain pipeline and commercial release management.

Mark is experienced in product research and development with over 15 patents and patents pending.

Mark holds a Master in Business Administration from Argosy University and Bachelor of Technology from Rochester Institute of Technology.